Finding the hidden gems Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi’s Make In India campaign By Viveka RoychowdhuryUpdated: November 5, 2015 11:19 IST
Balancing the scales Besides the balanced reasoning within the Delhi HC judgement, it is the SC’s intervention which could see this case go… By Viveka RoychowdhuryUpdated: October 13, 2015 12:11 IST
TC Biopharm to start phase II/III studies of ImmuniCell in October Currently focused on skin, renal and lung cancer, the platform has potential to treat all types of cancer tumours as… By Viveka RoychowdhuryOctober 7, 2015 20:00 IST
The Journey From Cow to Consumption Post Diwali, ColoPlus sachets will be launched in India, thanks to a collaboration between ColoPlus and the Rs 1,450 crore… By Viveka RoychowdhuryUpdated: October 7, 2015 16:04 IST
Mainstreaming AYUSH The last month saw a major milestone in the patent versus patient debate By Viveka RoychowdhuryUpdated: October 6, 2015 18:22 IST
The tipping point? The ongoing dengue infection has become fodder for the political mill in Delhi and while we all mourn the loss… By Viveka RoychowdhuryUpdated: October 8, 2015 17:55 IST
The journey from cow to consumption What does it take to transform bovine colostrum into a nutritional supplement, ensuring that all the immunoglobins, vitamins and other… By Viveka RoychowdhuryUpdated: September 24, 2015 17:40 IST
Playing for high stakes According to the latest data from the India Brand Equity Foundation (IBEF), the Indian domestic pharma market ended FY15 with… By Viveka RoychowdhurySeptember 14, 2015 11:13 IST
The rockstar of cardiac care Authors of a recent study published in PLoS ONE questioned the use of two commonly prescribed presurgical tests in the… By Viveka RoychowdhuryUpdated: September 9, 2015 13:39 IST
Mylan’s One Quality Standard a long way off Some industry observers are surprised that ‘significant violations’ of this nature have not warranted an import alert or ban By Viveka RoychowdhuryAugust 24, 2015 12:34 IST
Getting the science right The ‘no pain, no gain’ mantra seems to be finally putting the $25 billion AstraZeneca on the road to recovery,… By Viveka RoychowdhuryUpdated: August 21, 2015 14:56 IST
New strategies for growth After a decade of pain, there are some reassuring signs that the pharmaceutical industry may just be seeing the faint… By Viveka RoychowdhuryUpdated: August 20, 2015 12:40 IST
‘We want to be relevant to the Indian market’ Kimberly-Clark spun off its healthcare business to create a new entity, Halyard Health in order to sharpen its focus on… By Viveka RoychowdhuryUpdated: August 10, 2015 11:12 IST
Should docs fear online pharmacies? The Indian Medical Association (IMA) recently released a white paper detailing why the Indian government should not allow online pharmacies By Viveka RoychowdhuryUpdated: August 10, 2015 11:01 IST
Digital India: A new game needs new rules With the launch of the Digital India campaign in early July, it is time to relook India Pharma Inc’s engagement… By Viveka RoychowdhuryUpdated: August 5, 2015 11:24 IST
Cleanroom tech to go more hi tech Cleanrooms are perhaps one of the most crucial parts of the lifesciences sector, given that regulatory agencies are upping the… By Viveka RoychowdhuryJuly 24, 2015 15:50 IST
BI’s afatinib LUX-Lung 8 trial data released at ASCO 2015 Patients from 23 countries, including India, participated in the trial, which is reportedly the first prospective trial to directly compare… By Viveka RoychowdhuryJuly 22, 2015 13:50 IST
Lee Pharma revives the CL debate With little known Lee Pharma filing India’s third compulsory licensing (CL), legal eagles and everyone interested or connected to pharmaceutical… By Viveka RoychowdhuryUpdated: July 20, 2015 17:59 IST
Brazil’s Bolsonaro sentenced to 27 years for coup plot, becoming first ex-president jailed for attacking democracy
